Early Use of Corticosteroid May Prolong SARS-CoV-2 Shedding in Non-Intensive Care Unit Patients with COVID-19 Pneumonia: A Multicenter, Single-Blind, Randomized Control Trial.

X, Tang; YM, Feng; JX, Ni; JY, Zhang; LM, Liu; K, Hu; XZ, Wu; JX, Zhang; JW, Chen; JC, Zhang; J, Su; YL, Li; Y, Zhao; J, Xie; Z, Ding; XL, He; W, Wang; RH, Jin; HZ, Shi; B, Sun

doi:10.1159/000512063

Public

Early Use of Corticosteroid May Prolong SARS-CoV-2 Shedding in Non-Intensive Care Unit Patients with COVID-19 Pneumonia: A Multicenter, Single-Blind, Randomized Control Trial.

Shared by NobleBlocks on Jan 22, 2021 • 12:00 AM UTC

Authors:

Tang X

Feng YM

Ni JX

Abstract

<h4>Background</h4>There is still no clinical evidence available to support or to oppose corticosteroid treatment for coronavirus disease 2019 (COVID-19) pneumonia.<h4>Objective</h4>To investigate the efficacy and safety of corticosteroid given to the hospitalized patients with COVID-19 pneumonia.<h...

Subject

Pneumonia

corticosteroid

Outcome

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!